Clinical Trials Sponsored by Cancer and Allergy Foundation

Total 1444 results

National Institute of Allergy and Infectious Diseases...

Completed

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Inherited Immune Deficiencies

United States
National Institute of Allergy and Infectious Diseases...

Completed

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Ebola Virus

Liberia
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Challenge Infection of Healthy Adult Volunteers With RSV A2

Upper Respiratory Tract Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Retrospective Chart Review of Candida Fungemia

Candida Fungemia

United States
National Institute of Allergy and Infectious Diseases...

Completed

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

HIV | Healthy Volunteers

United States
National Institute of Allergy and Infectious Diseases...

Completed

Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals

HIV

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

HIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal Antibody

United States
National Institute of Allergy and Infectious Diseases...

Completed

Experimental Ebola Vaccine Trial

Healthy | Hemorrhagic Fever, Ebola

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults

Malaria

United States
National Institute of Allergy and Infectious Diseases...

Completed

Cause and Natural Course of Pediatric-Onset Mastocytosis

Mastocytosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali

Accute Falciparum Malaria

Mali
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Monoclonal Antibody, Human | HIV Antibodies | Neutralizing Antibody | Prevention of HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Genetic Factors in Atherosclerosis

Atherosclerosis

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Apheresis to Obtain Plasma and White Blood Cells in Malies

Malaria
National Institute of Allergy and Infectious Diseases...

Completed

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali

Lassa Virus Infection

Mali
National Institute of Allergy and Infectious Diseases...

Completed

Screening Protocol for HIV Vaccine Studies

HIV Infections | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Responses to Mycobacterium Tuberculosis

Mycobacterium Tuberculosis

Mali
National Institute of Allergy and Infectious Diseases...

Completed

Hepatitis B and HIV Co-Infection in Patients in Uganda

HIV Infections | Hepatitis B

Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis

Atopic Dermatitis

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders

Asthma | Allergy | Allergic Rhinitis | Atopic Dermatitis | Food Allergy | Mastocytosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Assessment of Alterations in Immune Function During Pregnancy and Post Parturition

Pregnancy Immune Function

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy

Immune Reconstitution Inflammatory Syndrome

United States, Thailand
National Institute of Allergy and Infectious Diseases...

Terminated

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Vaginal Candidiasis | Microbiome | Antibiotic-Induced VVC

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses

Healthy Volunteers | Abnormal Phagocyte Function

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

Hypotension | Angioedema | Anaphylaxis | Bronchospasm

United States
National Institute of Allergy and Infectious Diseases...

Completed

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

HIV, Inflammation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Malaria Studies in Cambodia

Malaria

Cambodia
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Healthy Adult Immune Responses to Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Completed

Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, Mali

Malaria

Mali
National Institute of Allergy and Infectious Diseases...

Completed

Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis

Tuberculosis | Urea Breath Test

Mali
National Institute of Allergy and Infectious Diseases...
National Institutes of Health Clinical Center (CC)

Terminated

Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections

HIV

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research

HIV | Tuberculosis

Mali
National Institute of Allergy and Infectious Diseases...

Terminated

People Presenting With Neurocysticercosis in North America

Neurocysticercosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease

CGD

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

Malaria | Severe Malaria

Mali
National Institute of Allergy and Infectious Diseases...

Terminated

Emtricitabine/Tenofovir Alafenamide as Salvage ART

HIV

United States
National Institute of Allergy and Infectious Diseases...

Completed

Leukapheresis for Research on HCV-Coinfected Patients

HIV Infections | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

IFN-Gamma Therapy | CGD Gene Mutation | CGD Response to IFNg | CGD - Chronic Granulomatous Disease | Immunodeficiency Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Influenza A Virus, H1N1 Subtype | Novel Swine-Origin

United States
National Institute of Allergy and Infectious Diseases...

Completed

Candidate HIV Vaccine

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine

Malaria

United States
National Institute of Allergy and Infectious Diseases...

Completed

G-CSF to Treat Crohn's Disease

Crohn's Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

HIV Infection | Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of West Nile Virus Vaccine

West Nile Fever

United States
National Institute of Allergy and Infectious Diseases...

Completed

Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali

Malaria

United States

Clinical Trials Sponsored by Cancer and Allergy Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations